[1]
|
Uchibori, T., Matsuda, K., Shimodaira, T., Sugano, M., Uehara, T. and Honda, T. (2017) IL-6 Trans-Signaling Is another Pathway to Upregulate Osteopontin. Cytokine, 90, 88-95. https://doi.org/10.1016/j.cyto.2016.11.006
|
[2]
|
Lok, S.I., Nous, F.M., Van Kuik, J., van der Weide, P., Winkens, B., Kemperman, H., et al. (2015) Myocardial Fibrosis and Pro-Fibrotic Markers in End-Stage Heart Failure Patients during Continuous-Flow Left Ventricular Assist Device Sup-port. European Journal of Cardio-Thoracic Surgery, 48, 407-415. https://doi.org/10.1093/ejcts/ezu539
|
[3]
|
Icer, M.A. and Gezmen-Karadag, M. (2018) The Multiple Functions and Mechanisms of Osteopontin. Clinical Biochemistry, 59, 17-24. https://doi.org/10.1016/j.clinbiochem.2018.07.003
|
[4]
|
Ahmed, M. and Kundu, G.C. (2010) Osteopon-tin Selectively Regulates p70S6K/mTOR Phosphorylation Leading to NF-κB Dependent AP-1-Mediated ICAM-1 Ex-pression in Breast Cancer Cells. Molecular Cancer, 9, Article No. 101.
https://doi.org/10.1186/1476-4598-9-101
|
[5]
|
Li, Y., Jiang, W., Wang, H., Deng, Z., Zeng, C., Tu, M., et al. (2016) Osteopontin Promotes Expression of Matrix Metalloproteinase 13 through NF-κB Signaling in Osteoarthritis. BioMed Research International, 2016, Article ID: 6345656.
https://doi.org/10.1155/2016/6345656
|
[6]
|
Hoac, B., Nelea, V., Jiang, W., Kaartinen, M.T. and McKee, M.D. (2017) Mineralization-Inhibiting Effects of Transglutaminase-Crosslinked Polymeric Osteopontin. Bone, 101, 37-48. https://doi.org/10.1016/j.bone.2017.04.007
|
[7]
|
Denhardt, D.T. and Guo, X. (1993) Osteopontin: A Protein with Diverse Functions. The FASEB Journal, 7, 1475-1482.
https://doi.org/10.1096/fasebj.7.15.8262332
|
[8]
|
Cao, D.X., Li, Z.J., Jiang, X.O., Lum, Y.L., Khin, E., Lee, N.P., et al. (2012) Osteopontin as Potential Biomarker and Therapeutic Target in Gastric and Liver Cancers. World Journal of Gastroenterology, 18, 3923-3930.
https://doi.org/10.3748/wjg.v18.i30.3923
|
[9]
|
Kläning, E., Christensen, B., Bajic, G., Hoffmann, S.V., Jones, N.C., Callesen, M.M., et al. (2015) Multiple Low- Affinity Interactions Support Binding of Human Osteopontin to In-tegrin αXβ2. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1854, 930-938. https://doi.org/10.1016/j.bbapap.2015.03.008
|
[10]
|
Streuli, I., Santulli, P., Chouzenoux, S., Chapron, C. and Batteux, F. (2017) Serum Osteopontin Levels Are Decreased in Focal Adenomyosis. Reproductive Sciences, 24, 773-782. https://doi.org/10.1177/1933719116669054
|
[11]
|
Hu, Z.D., Wei, T.T., Yang, M., Ma, N., Tang, Q.-Q., Qin, B.-D., et al. (2015) Diagnostic Value of Osteopontin in Ovarian Cancer: A Meta-Analysis and Systematic Review. PLOS ONE, 10, e0126444.
https://doi.org/10.1371/journal.pone.0126444
|
[12]
|
Tian, F., Zhou, P., Kang, W., Luo, L., Fan, X., Yan, J., et al. (2015) The Small-Molecule Inhibitor Selectivity between IKKα and IKKβ Kinases in NF-κB Signaling Pathway. Journal of Receptors and Signal Transduction, 35, 307-318.
https://doi.org/10.3109/10799893.2014.980950
|
[13]
|
Sun, S.C. (2017) The Non-Canonical NF-κB Pathway in Immunity and Inflammation. Nature Reviews Immunology, 17, 545-558. https://doi.org/10.1038/nri.2017.52
|
[14]
|
Kawai, T. and Akira, S. (2010) The Role of Pattern-Recognition Receptors in Innate Immunity: Update on Toll-Like Receptors. Nature Immunology, 11, 373-384. https://doi.org/10.1038/ni.1863
|
[15]
|
唐一萍, 冯俊, 马鹏. 骨桥蛋白与炎症分子核因子κB在中耳胆脂瘤上皮组织中的表达及相关性分析[J]. 成都医学院学报, 2020, 15(3): 328-331.
|
[16]
|
张向峰, 刘芬, 朱光发, 王增智. 重组骨桥蛋白通过抑制核因子κB和基质金属蛋白酶2和9减轻高氧急性肺损伤[J]. 中国呼吸与危重监护杂志, 2014, 13(4): 364-369.
|
[17]
|
Häcker, H. and Karin, M. (2006) Regulation and Function of IKK and IKK-Related Kinases. Science’s STKE, 2006, Article No. re13. https://doi.org/10.1126/stke.3572006re13
|
[18]
|
Ruland, J. (2011) Return to Homeostasis: Downregulation of NF-κB Responses. Nature Immunology, 12, 709-914.
https://doi.org/10.1038/ni.2055
|
[19]
|
Azuma, Y., Taniguchi, F., Nakamura, K., Nagira, K., Khine, Y.M., Kiyama, T., et al. (2017) Lipopolysaccharide Promotes the Development of Murine Endometriosis-Like Lesions via the Nuclear Factor-κB Pathway. American Journal of Reproductive Immunology, 77, Article No. e12631. https://doi.org/10.1111/aji.12631
|
[20]
|
Ito-Kureha, T., Koshikawa, N., Yamamoto, M., Semba, K., Yamaguchi, N., Yamamoto, T., et al. (2015) Tropomodulin 1 Expression Driven by NF-κB Enhances Breast Cancer Growth. Cancer Research, 75, 62-72.
https://doi.org/10.1158/0008-5472.CAN-13-3455
|
[21]
|
Zhang, J., Yamada, O., Kida, S., Matsushita, Y., Murase, S., Hattori, T., et al. (2016) Identification of Brefelamide as a Novel Inhibitor of Osteopontin That Suppresses Invasion of A549 Lung Cancer Cells. Oncology Reports, 36, 2357- 2364. https://doi.org/10.3892/or.2016.5006
|
[22]
|
Qin, L. (2014) Osteopontin Is a Promoter for Hepatocellular Carcinoma Metastasis: A Summary of 10 Years of Studies. Fron-tiers of Medicine, 8, 24-32. https://doi.org/10.1007/s11684-014-0312-8
|
[23]
|
Chen, Y.J., Wei, Y.Y., Chen, H.T., Fong, Y.-C., Hsu, C.-J., Tsai, C.-H., et al. (2009) Osteopontin Increases Migration and MMP-9 Up-Regulation via αVβ3 Integrin, FAK, ERK, and NF-κB-Dependent Pathway in Human Chondrosarcoma Cells. Journal of Cellular Physiology, 221, 98-108. https://doi.org/10.1002/jcp.21835
|
[24]
|
Urtasun, R., Lopategi, A., George, J., Leung, T.-M., Lu, Y., Wang, X., et al. (2012) Osteopontin, An Oxidant Stress Sensitive Cytokine, Up-Regulates Collagen-I via Integrin αVβ3 Engagement and PI3K/pAkt/NFκB Signaling. Hepatology, 55, 594-608. https://doi.org/10.1002/hep.24701
|
[25]
|
Guarneri, C., Bevelacqua, V., Polesel, J., Falzone, L., Cannavò, P.S., Span-didos, D.A., et al. (2017) NF-κB Inhibition Is Associated with OPN/MMP-9 Downregulation in Cutaneous Melanoma. Oncology Reports, 37, 737-746.
https://doi.org/10.3892/or.2017.5362
|
[26]
|
Liu, J., Liu, Q., Wan, Y., Zhao, Z., Yu, H., Luo, H., et al. (2014) Oste-opontin Promotes the Progression of Gastric Cancer through the NF-κB Pathway Regulated by the MAPK and PI3K. International Journal of Oncology, 45, 282-290.
https://doi.org/10.3892/ijo.2014.2393
|
[27]
|
Guo, H., Cai, C.Q., Schroeder, R.A. and Kuo, P.C. (2001) Osteopontin Is a Negative Feedback Regulator of Nitric Oxide Synthesis in Murine Macrophages. The Journal of Immunology, 166, 1079-1086.
https://doi.org/10.4049/jimmunol.166.2.1079
|
[28]
|
Minai-Tehrani, A., Chang, S.H., Kwon, J.T., Hwang, S.K., Kim, J.E., Shin, J.Y., et al. (2013) Aerosol Delivery of Lentivirus-Mediated O-Glycosylation Mutant Osteopontin Suppresses Lung Tumorigenesis in K-rasLA1 Mice. Cellular Oncology, 36, 15-26. https://doi.org/10.1007/s13402-012-0107-3
|
[29]
|
Suzuki, H., Hasegawa, Y., Ayer, R., Sugawara, T., Chen, W., Sozen, T., et al. (2011) Effects of Recombinant Osteopontin on Blood-Brain Barrier Disruption after Subarachnoid Hemorrhage in Rats. In: Zhang, J. and Colohan, A., Eds., Intracerebral Hemorrhage Research, Vol. 111, 231-236. https://doi.org/10.1007/978-3-7091-0693-8_39
|
[30]
|
Matušan-Ilijaš, K., Damante, G., Fabbro, D., Dorđević, G., Hadžisejdić, I., Grahovac, M., et al. (2011) Osteopontin Expression Correlates with Nuclear Factor-κB Activation and Apoptosis Downregulation in Clear Cell Renal Cell Carcinoma. Pathology - Research and Practice, 207, 104-110. https://doi.org/10.1016/j.prp.2010.11.004
|